Canada Pension Plan Investment Board’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.57M | Buy |
510,341
+499,700
| +4,696% | +$4.48M | ﹤0.01% | 722 |
|
2025
Q1 | $79.8K | Hold |
10,641
| – | – | ﹤0.01% | 1161 |
|
2024
Q4 | $80K | Hold |
10,641
| – | – | ﹤0.01% | 1276 |
|
2024
Q3 | $80.9K | Sell |
10,641
-103,159
| -91% | -$784K | ﹤0.01% | 1194 |
|
2024
Q2 | $703K | Hold |
113,800
| – | – | ﹤0.01% | 1038 |
|
2024
Q1 | $578K | Hold |
113,800
| – | – | ﹤0.01% | 1094 |
|
2023
Q4 | $682K | Hold |
113,800
| – | – | ﹤0.01% | 1002 |
|
2023
Q3 | $806K | Hold |
113,800
| – | – | ﹤0.01% | 884 |
|
2023
Q2 | $801K | Hold |
113,800
| – | – | ﹤0.01% | 859 |
|
2023
Q1 | $949K | Sell |
113,800
-70,900
| -38% | -$591K | ﹤0.01% | 906 |
|
2022
Q4 | $2.12M | Buy |
184,700
+176,600
| +2,180% | +$2.03M | ﹤0.01% | 710 |
|
2022
Q3 | $102K | Buy |
+8,100
| New | +$102K | ﹤0.01% | 1081 |
|
2022
Q1 | – | Sell |
-215
| Closed | -$3K | – | 1326 |
|
2021
Q4 | $3K | Buy |
+215
| New | +$3K | ﹤0.01% | 1416 |
|
2020
Q1 | – | Sell |
-749,200
| Closed | -$2.59M | – | 1301 |
|
2019
Q4 | $2.59M | Buy |
+749,200
| New | +$2.59M | 0.01% | 794 |
|